Literature DB >> 33568241

Cochlear implantation in children with Mondini dysplasia: our experience.

N M Suri1, A R Prasad1, R K Sayani1, A Anand2, G Jaychandran2.   

Abstract

OBJECTIVE: This study details the intra-operative complications, and compares auditory scales post-implantation of either profoundly deaf young children with radiologically normal inner ears (group A) or children with Mondini dysplasia (group B).
METHODS: A retrospective survey was carried out of 338 patients with severe to profound sensorineural hearing loss who underwent cochlear implant surgery from February 2015 to May 2017. Patients were divided into 2 groups of 27 patients each. Both groups were followed up to three years post-implantation.
RESULTS: Cerebrospinal fluid ooze developed in 12 patients, and 2 patients had a cerebrospinal fluid 'gusher', one of which had to be explored within 24 hours. After implant use for one year, both groups had similar speech perception scores.
CONCLUSION: The cerebrospinal fluid gusher in Mondini dysplasia should be anticipated and adequately managed intra-operatively. This study highlights the tailoring of a post-implantation rehabilitation programme according to individual needs.

Entities:  

Keywords:  Cerebrospinal Fluid; Cochlear Implants

Mesh:

Year:  2021        PMID: 33568241     DOI: 10.1017/S0022215121000372

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Electrically evoked auditory brainstem responses in deaf patients with Mondini malformation during cochlear implantation.

Authors:  Han-Yu Zhu; Li Chen; Xiao-Yan Hou; Zheng-Quan Tang; Jia-Qiang Sun; Jing-Wu Sun; Xiao-Tao Guo
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-03-05       Impact factor: 3.236

2.  Systematic review of cochlear implantation in patients with inner ear malformations.

Authors:  Sunny Shah; Rameen Walters; Jake Langlie; Camron Davies; Ariel Finberg; Maria-Pia Tuset; Dario Ebode; Rahul Mittal; Adrien A Eshraghi
Journal:  PLoS One       Date:  2022-10-21       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.